Eloxx Pharmaceuticals, Inc. (ELOX) Social Stream
ELOXX PHARMACEUTICALS INC (ELOX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ELOXX PHARMACEUTICALS INC.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-08 | 4 | $5 | $3 | $3.775 | $3.82 | -1.18% |
2021-11-11 | 4 | $5 | $2 | $3.525 | $3.82 | -7.72% |
2021-11-18 | 4 | $5 | $1 | $3.275 | $3.82 | -14.27% |
2021-12-17 | 5 | $5 | $1 | $3.42 | $3.82 | -10.47% |
2022-01-21 | 4 | $4 | $1 | $3.02 | $3.82 | -20.94% |
2022-05-08 | 5 | $4 | $1 | $3.02 | $3.82 | -20.94% |
2022-05-10 | 5 | $4 | $0.5 | $2.92 | $3.82 | -23.56% |
2022-05-23 | 5 | $4 | $0.5 | $2.42 | $3.82 | -36.65% |
2022-08-25 | 3 | $4 | $0.5 | $2 | $3.82 | -47.64% |
2022-09-15 | 1 | $120 | $120 | $120 | $3.82 | 3041.36% |
2023-05-16 | 1 | $50 | $50 | $50 | $3.82 | 1208.9% |
2023-07-11 | 1 | $55 | $55 | $55 | $3.82 | 1339.79% |
2023-09-14 | 1 | $60 | $60 | $60 | $3.82 | 1470.68% |
Price Target Last Issued September 15, 2022
The Trend in the Analyst Price Target
ELOX's average price target has moved up $56.22 over the prior 24 months.
ELOX reports an average of 900.85% for its upside potential over the past 36 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-02-09 | 1 | 50 | 50 | 50 | 4.07 | 1128.5% |
2023-04-05 | 1 | 50 | 50 | 50 | 4.21 | 1087.65% |
2023-05-16 | 1 | 50 | 50 | 50 | 8.32 | 500.96% |
2023-07-11 | 1 | 55 | 55 | 55 | 7.58 | 625.59% |
2023-09-14 | 1 | 60 | 60 | 60 | 5.43 | 1004.97% |
ELOX Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 21 months, ELOX's average broker recommendation rating improved by 0.4.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ELOX as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, ELOXX PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 461.55% of them.
- In terms of how ELOXX PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 429.66% of that group.
- To contextualize these metrics, consider that out of Business Services stocks, ELOXX PHARMACEUTICALS INC's number of analysts covering the stock is greater than 125.73% of them.
- ELOXX PHARMACEUTICALS INC's variance in analysts' estimates is lower than -935.63% of stocks in the small market cap category.
In the Business Services industry, NRC, SNCE, and ABSI are the three stocks most similar to ELOXX PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding ELOX using the data that counts. Try POWR Ratings for free.